Encompass Health (NYSE:EHC) Issues Quarterly Earnings Results

Encompass Health (NYSE:EHCGet Rating) issued its quarterly earnings data on Wednesday. The company reported $0.97 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.93 by $0.04, MarketWatch Earnings reports. The business had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.32 billion. Encompass Health had a return on equity of 19.20% and a net margin of 8.05%. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.05 EPS. Encompass Health updated its FY22 guidance to $3.83-4.19 EPS.

Shares of Encompass Health stock opened at $68.36 on Friday. The business has a 50 day simple moving average of $69.25 and a two-hundred day simple moving average of $65.96. Encompass Health has a 12 month low of $56.31 and a 12 month high of $88.58. The stock has a market capitalization of $6.80 billion, a P/E ratio of 16.63, a PEG ratio of 2.49 and a beta of 0.99. The company has a debt-to-equity ratio of 1.38, a current ratio of 1.23 and a quick ratio of 1.23.

The firm also recently declared a quarterly dividend, which was paid on Monday, April 18th. Investors of record on Friday, April 1st were issued a $0.28 dividend. The ex-dividend date was Thursday, March 31st. This represents a $1.12 dividend on an annualized basis and a yield of 1.64%. Encompass Health’s payout ratio is 27.25%.

Several equities analysts have recently issued reports on EHC shares. StockNews.com started coverage on Encompass Health in a report on Thursday, March 31st. They issued a “hold” rating for the company. TheStreet raised Encompass Health from a “c+” rating to a “b-” rating in a report on Tuesday, March 15th. Credit Suisse Group decreased their price objective on Encompass Health from $84.00 to $77.00 in a report on Thursday, February 3rd. Deutsche Bank Aktiengesellschaft decreased their price objective on Encompass Health from $95.00 to $80.00 in a report on Thursday, January 20th. Finally, Zacks Investment Research raised Encompass Health from a “sell” rating to a “hold” rating and set a $76.00 price objective for the company in a report on Monday, April 11th. Two research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $83.89.

Institutional investors have recently made changes to their positions in the business. EverSource Wealth Advisors LLC acquired a new position in shares of Encompass Health during the fourth quarter valued at approximately $78,000. Virtu Financial LLC acquired a new position in shares of Encompass Health during the fourth quarter valued at approximately $297,000. MML Investors Services LLC raised its holdings in shares of Encompass Health by 7.4% during the fourth quarter. MML Investors Services LLC now owns 7,128 shares of the company’s stock valued at $465,000 after acquiring an additional 490 shares during the last quarter. LPL Financial LLC raised its holdings in shares of Encompass Health by 46.1% during the third quarter. LPL Financial LLC now owns 16,271 shares of the company’s stock valued at $1,221,000 after acquiring an additional 5,131 shares during the last quarter. Finally, Metropolitan Life Insurance Co NY raised its holdings in shares of Encompass Health by 2.2% during the fourth quarter. Metropolitan Life Insurance Co NY now owns 20,368 shares of the company’s stock valued at $1,329,000 after acquiring an additional 431 shares during the last quarter. 92.35% of the stock is owned by institutional investors and hedge funds.

About Encompass Health (Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

See Also

Earnings History for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.